Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer

Two decades ago, Galectin-8 was described as a prostate carcinoma biomarker since it is only expressed in the neoplastic prostate, but not in the healthy tissue. To date, no biological function has been attributed to Galectin-8 that could explain this differential expression. In this study we silenc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentilini, Lucas Daniel, Jaworski, Felipe Martín, Tiraboschi, Carolina, Pérez, Ignacio González, Kotler, Monica Lidia, Chauchereau, Anne, Laderach, Diego Jose, Compagno, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546508/
https://www.ncbi.nlm.nih.gov/pubmed/28591719
http://dx.doi.org/10.18632/oncotarget.17963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5546508/
https://www.ncbi.nlm.nih.gov/pubmed/28591719
http://dx.doi.org/10.18632/oncotarget.17963

Ejemplares similares